Difficulty: Medium
Average Score: 81%
Practice
Nifedipine, a dihydropyridine calcium channel blocker:
Correct answer
B
Rationale
In clinical pharmacology, understanding the properties of cardiovascular drugs like Nifedipine is crucial for safe and effective patient care. The correct answer is B) Can be combined with beta blockers in the management of hypertension.
Nifedipine is a dihydropyridine calcium channel blocker that primarily dilates arteries more than veins. It is commonly used to treat hypertension and angina. When used alone, it can cause reflex tachycardia, which can be attenuated by combining it with a beta blocker. This combination therapy is often utilized in managing hypertension to achieve better blood pressure control without the negative effects of reflex tachycardia.
Options A, C, and D are incorrect:
A) Nifedipine dilates arteries more than veins due to its selective action on vascular smooth muscle.
C) Nifedipine does not increase plasma calcium concentration; rather, it inhibits the influx of calcium ions into vascular smooth muscle cells.
D) Nifedipine is not contraindicated in asthma; however, caution is advised in patients with heart failure or bradycardia.
Educationally, this question highlights the importance of understanding the mechanisms of action and appropriate combinations of cardiovascular drugs to optimize treatment outcomes in patients with hypertension. It reinforces the concept of combination therapy in managing complex conditions and underscores the need for a comprehensive understanding of drug actions to make informed clinical decisions.
Nifedipine is a dihydropyridine calcium channel blocker that primarily dilates arteries more than veins. It is commonly used to treat hypertension and angina. When used alone, it can cause reflex tachycardia, which can be attenuated by combining it with a beta blocker. This combination therapy is often utilized in managing hypertension to achieve better blood pressure control without the negative effects of reflex tachycardia.
Options A, C, and D are incorrect:
A) Nifedipine dilates arteries more than veins due to its selective action on vascular smooth muscle.
C) Nifedipine does not increase plasma calcium concentration; rather, it inhibits the influx of calcium ions into vascular smooth muscle cells.
D) Nifedipine is not contraindicated in asthma; however, caution is advised in patients with heart failure or bradycardia.
Educationally, this question highlights the importance of understanding the mechanisms of action and appropriate combinations of cardiovascular drugs to optimize treatment outcomes in patients with hypertension. It reinforces the concept of combination therapy in managing complex conditions and underscores the need for a comprehensive understanding of drug actions to make informed clinical decisions.